Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:MSTR News 12 January 2026 - 17 January 2026

Why Strategy stock (MSTR) is moving after hours as Wall Street trims targets ahead of Feb. 5 earnings

Why Strategy stock (MSTR) is moving after hours as Wall Street trims targets ahead of Feb. 5 earnings

Strategy Inc shares rose 1.6% to $173.71 in after-hours trading Friday after a filing showed it raised $1.25 billion by selling stock and used the funds to buy 13,627 bitcoin. Mizuho and TD Cowen both cut their price targets but kept positive ratings. The company now holds 687,410 bitcoin. Strategy will report fourth-quarter earnings on Feb. 5.
17 January 2026
··
Strategy (MSTR) stock hovers near $171 as bitcoin dips and analysts trim targets before earnings

Strategy (MSTR) stock hovers near $171 as bitcoin dips and analysts trim targets before earnings

Strategy Inc shares edged up 0.04% to $170.98 Friday, while bitcoin fell 1.6% to $94,878. Mizuho and TD Cowen cut their price targets to $403 and $440, respectively, but kept positive ratings. Strategy raised $1.25 billion by selling stock and used it to buy 13,627 bitcoin, bringing its total holdings to 687,410. Fourth-quarter results are set for release after the market closes on Feb. 5.
16 January 2026
··
Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next

Strategy Inc stock drops as Senate crypto bill delay hits bitcoin — what investors watch next

Strategy Inc. (MSTR) fell 4.7% to $170.91 Thursday as bitcoin slid 2% late in the session and crypto stocks dropped. The U.S. Senate Banking Committee postponed debate on a crypto market-structure bill after Coinbase’s CEO criticized the draft. Coinbase shares dropped 6.5%, Robinhood 7.8%. Strategy will report fourth-quarter results after markets close Feb. 5.
15 January 2026
···
Strategy (MSTR) stock rises after $1.25 billion Bitcoin buy as crypto rallies on CPI, Washington chatter

Strategy (MSTR) stock rises after $1.25 billion Bitcoin buy as crypto rallies on CPI, Washington chatter

Strategy Inc shares rose 3.7% to $179.33 after the company disclosed a $1.25 billion purchase of 13,627 bitcoins, funded by selling shares. Bitcoin climbed 3.3% to $97,490, boosting crypto-linked stocks. Investors are watching Thursday’s Senate Banking Committee review of the Digital Asset Market Clarity Act. Director Carl J. Rickertsen bought 5,000 company shares at $155.88 each.
14 January 2026
·····
Coinbase stock jumps as bitcoin rallies past $97,000 — and a network outage warning hits mid-session

Coinbase stock jumps as bitcoin rallies past $97,000 — and a network outage warning hits mid-session

Coinbase shares rose 3.8% to $262.17 after bitcoin jumped 4.2% to about $97,467. The company reported delays for Sui network transfers but said buying, selling, and fiat moves were unaffected. The U.S. Senate will debate a crypto market-structure bill Thursday. France’s regulator said 30% of crypto firms lack clarity on MiCA licensing; Coinbase already holds one.
14 January 2026
·····
MSTR pops after Strategy’s $1.25B bitcoin buy — and its ‘Stretch’ stock is doing more of the lifting

MSTR pops after Strategy’s $1.25B bitcoin buy — and its ‘Stretch’ stock is doing more of the lifting

Bitcoin jumped past $96,000 after Strategy announced a $1.25 billion bitcoin purchase, funded partly by new variable-rate preferred stock, STRC. Director Carl Rickertsen bought 5,000 common shares Monday, the first insider purchase since 2022. The company now holds 687,410 bitcoin. STRC traded $175.7 million Monday, nearly triple its 30-day average.
14 January 2026
··
Bitcoin price today: Senate crypto bill lifts Coinbase, Strategy as bitcoin nears $95,000 in premarket

Bitcoin price today: Senate crypto bill lifts Coinbase, Strategy as bitcoin nears $95,000 in premarket

Bitcoin rose nearly 3% to $94,900 in premarket trading Wednesday, with Coinbase and Strategy leading gains among U.S.-listed crypto stocks. Traders are watching Thursday’s Senate Banking Committee markup on the CLARITY Act, which could affect stablecoin rewards and regulatory oversight. Strategy disclosed a $1.25 billion bitcoin purchase last week. U.S. inflation data showed a 0.3% rise in December consumer prices.
14 January 2026
·····
Strategy (MSTR) stock jumps after-hours after $1.25 billion bitcoin buy

Strategy (MSTR) stock jumps after-hours after $1.25 billion bitcoin buy

Strategy Inc (MSTR.O) jumped 6.7% to $172.99 in after-hours trading after disclosing it bought 13,627 bitcoin for $1.25 billion last week, raising its total holdings to 687,410 bitcoin. The company funded the purchases through at-the-market stock sales, netting about $1.25 billion. Bitcoin rose 4.6% to near $95,417 Tuesday. Director Carl J. Rickertsen bought 5,000 shares at an average $155.88 each.
14 January 2026
···
Bitcoin price jumps above $94,000 after U.S. inflation data; Coinbase, Strategy stocks climb late

Bitcoin price jumps above $94,000 after U.S. inflation data; Coinbase, Strategy stocks climb late

Bitcoin rose 3.2% to $94,074 Tuesday after U.S. inflation data and news of a Senate draft bill assigning crypto spot market oversight to the CFTC. Coinbase shares gained 4% and Strategy jumped 6.7% after revealing a $1.25 billion bitcoin purchase. BitGo announced terms for a planned U.S. IPO. Senate committee discussion on the crypto bill is set for Thursday.
13 January 2026
·····
Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock

Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock

Bitcoin rose 2.2% to $93,478 Tuesday, with Coinbase up 3% and Strategy gaining 4.2% after disclosing a $1.25 billion bitcoin purchase. U.S.-listed spot bitcoin ETFs advanced about 2.3%. Senators late Monday released draft legislation to clarify crypto rules, granting the CFTC more oversight. December CPI rose 0.3%, keeping annual inflation at 2.7% ahead of the Jan. 27-28 Fed meeting.
13 January 2026
·······
Coinbase stock rises as Senate revives CLARITY Act crypto bill — stablecoin rewards in play

Coinbase stock rises as Senate revives CLARITY Act crypto bill — stablecoin rewards in play

Bitcoin rose 1.4% to near $91,900 and Coinbase gained 0.9% in premarket trading after Senate Banking released updated crypto bill text ahead of a Jan. 15 vote. The bill would clarify SEC and CFTC oversight of digital assets. Senate Agriculture delayed its own markup to late January. The manager’s amendment would ban interest payments on payment stablecoins.
13 January 2026
······
Bitcoin price jumps toward $92,000 as U.S. crypto bill draft lands; Coinbase, Strategy rise premarket

Bitcoin price jumps toward $92,000 as U.S. crypto bill draft lands; Coinbase, Strategy rise premarket

Bitcoin rose 1.7% to $92,040 early Tuesday, with crypto stocks including Coinbase and Marathon Digital also gaining in premarket trading. A Senate draft bill would bar digital-asset firms from paying interest on payment stablecoins, while requiring new disclosure rules. Strategy disclosed it bought 13,627 bitcoin last week for $1.25 billion. U.S. CPI data and a Senate crypto bill markup are due this week.
13 January 2026
·····
Strategy’s $1.25 billion bitcoin buy nudges MSTR stock higher premarket

Strategy’s $1.25 billion bitcoin buy nudges MSTR stock higher premarket

Strategy shares rose nearly 3% in premarket trading Tuesday after the company disclosed a $1.25 billion bitcoin purchase. SEC filings show Strategy bought 13,627 bitcoins at an average price of $91,519 each, raising its total holdings to 687,410 coins. The purchase was funded by $1.25 billion in proceeds from recent share sales. Bitcoin traded near $92,135 after the announcement.
13 January 2026
···
Strategy stock jumps after-hours as MSTR buys $1.25 billion of bitcoin again — what investors watch next

Strategy stock jumps after-hours as MSTR buys $1.25 billion of bitcoin again — what investors watch next

Strategy Inc. bought 13,627 bitcoin for $1.25 billion last week, raising its total holdings to 687,410 BTC, funded by selling $1.25 billion in new shares. MSTR stock rose about 3% in after-hours trading. The company’s average purchase price was $91,519 per bitcoin. Strategy reported a $17.44 billion unrealized loss on its digital assets earlier this month.
12 January 2026
··
Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin rose 0.3% to $91,147 Monday as Coinbase and Marathon Digital shares also gained. Fed Chair Jerome Powell confirmed the Justice Department served the central bank with grand jury subpoenas, sending the dollar lower and gold to a record above $4,600 an ounce. Strategy bought 13,627 bitcoin last week, bringing its holdings to 687,410. Traders await Tuesday’s U.S. CPI report and the Fed’s Jan. 27-28 meeting.
12 January 2026
······
1 2 3 4 5 … 8

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop